Literature DB >> 31843073

Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion.

.   

Abstract

Patients preparing to undergo gonadotoxic medical therapy, radiation therapy, or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation for iatrogenic infertility. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document with a similar name, last published in 2013.
Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31843073     DOI： 10.1016/j.fertnstert.2019.09.013

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  79 in total

Review 1.  Update on fertility preservation for younger women with breast cancer.

Authors:  Ellen Warner; Karen Glass; Shu Foong; Emily Sandwith
Journal:  CMAJ       Date:  2020-08-31       Impact factor: 8.262

Review 2.  Spermatogonial Stem Cell Culture in Oncofertility.

Authors:  Sherin David; Kyle E Orwig
Journal:  Urol Clin North Am       Date:  2020-05       Impact factor: 2.241

3.  First pregnancy and live birth in Turkey following frozen-thawed ovarian tissue transplantation in a patient with acute lymphoblastic leukemia who underwent cord blood transplantation.

Authors:  Murat Sonmezer; Sinan Ozkavukcu; Yavuz Emre Sukur; Duygu Kankaya; Onder Arslan
Journal:  J Assist Reprod Genet       Date:  2020-06-16       Impact factor: 3.412

4.  Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.

Authors:  Kutluk H Oktay; Giuliano Bedoschi; Shari B Goldfarb; Enes Taylan; Shiny Titus; Glenn E Palomaki; Tessa Cigler; Mark Robson; Maura N Dickler
Journal:  Fertil Steril       Date:  2020-04-22       Impact factor: 7.329

5.  Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin.

Authors:  Soner Celik; Sinan Ozkavukcu; Ciler Celik-Ozenci
Journal:  J Assist Reprod Genet       Date:  2020-07-10       Impact factor: 3.412

6.  Ethical issues involving fertility preservation for transgender youth.

Authors:  Rebecca M Harris; Irini N Kolaitis; Joel E Frader
Journal:  J Assist Reprod Genet       Date:  2020-08-11       Impact factor: 3.412

7.  Ovarian tissue cryopreservation and novel bioengineering approaches for fertility preservation.

Authors:  Andrea S K Jones; Ariella Shikanov
Journal:  Curr Breast Cancer Rep       Date:  2020-11-04

8.  Consult and procedure incidence outcomes following establishment of a fertility preservation program for children with cancer.

Authors:  Supriya Behl; Vidhu B Joshi; Reda S Hussein; David L Walker; Kari L Lampat; Anthony G Krenik; Kathrynne M Barud; Jolene R Fredrickson; Terri M Galanits; Katherine J Rian; Adriana M Delgado; Julia H Byrne; Dean Potter; Siobhan T Pittock; Carola A S Arndt; Yulian Zhao; Patricio C Gargollo; Candace F Granberg; Zaraq Khan; Asma J Chattha
Journal:  J Assist Reprod Genet       Date:  2021-01-03       Impact factor: 3.412

Review 9.  Hormonal Stimulation of Human Ovarian Xenografts in Mice: Studying Folliculogenesis, Activation, and Oocyte Maturation.

Authors:  Monica Anne Wall; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

Review 10.  Fertility Options for the Transgender and Gender Nonbinary Patient.

Authors:  Allison C Mayhew; Veronica Gomez-Lobo
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.